Anita Khalil, Vikram Prakash and Jayashree
Bhattacharjee#
Department of Pediatrics, Maulana Azad Medical
College, New Delhi 110 002 and Department of Biochemistry, Lady
Hardinge Medical College, New Delhi 110 001.
Correspondence to: Dr. Anita Khalil, Type 6/1, MAMC
Campus, Kotla Road, New Delhi 110 002.
E-mail: [email protected]
Manuscript received: September 19, 2002, Initial
review completed: November 7, 2002,
Revision accepted: June 5, 2003.
Abstract:
Objective: To determine serum levels of
insulin, glucose and lipid profile in children of young parents with
CAD. Design: Cohort study. Setting: Tertiary care teaching
hospital. Methods: Fifty children in the 5-18 years age group
of young parents (< 45 years) with CAD, evaluated for fasting blood
glucose, insulin and lipid profile compared with children of normal
parents in the same age group. Results: Serum total and LDL-Cholesterol,
blood sugar and B.P., both systolic and diastolic were significantly
higher in test group as compared to controls though there was no
significant difference observed for weight and body mass index (BMI)
between the two groups. The insulin levels were also significantly
high in the test cases.
Key words: Children, Coronary artery disease,
Insulin.
Coronary artery disease (CAD) is the
most important clinical manifestation of atherosclerosis, which is
responsible for a higher incidence, prevalence and mortality in the
Asian Indians in the US as compared to the western counterparts(1).
Since 1960, life expectancy in India has increased by 20 years, that
is up to 61 years of age(2) and from 1960 to 1995, the prevalence of
CAD in adults has increased from 3% to 10%, in urban Indians and from
2% to 4% in rural Indians, with women having rates similar to men(3).
Although the prevalence of CAD in rural India is half that of urban
India, this is still two - fold higher than the overall CAD rates in
the US and several fold higher than those in rural China(4). In 1990,
there were 783,000 deaths due to CAD in India, which is expected to
double by the year 2015(5). Young Indians with CAD have extensive
multi- vessel coronary atherosclerosis, which has been associated with
obesity, hypertension and also with an emergence of a new metabolic
cluster -Insulin resistance syndrome (Syndrome X)(6).
Recently it has become clear that insulin
resistance is an independent risk factor for the development of
atherosclerosis(7). Syndrome X is a clinico-metabolic cluster
consisting of obesity (elevated waist-hip ratio) with hypertension,
dyslipidemia and with elevated insulin levels(8). The dyslipidemia
demonstrated has 3 major components: elevated total and low-density
lipoprotein cholesterol (LDL-C) with small and more dense components
and with overproduction of very low density lipoprotein (VLDL),
elevated triglycerides and decreased high density lipo-protein
cholesterol (HDL-C). Insulin was found to be a weak but positive
indicator of CAD in a meta-analysis of prospective population study(9)
and was also ratified by the Quebec Cardio-Vascular Study(10). Insulin
resistance predicts the onset of diabetes type 2 in a selected
genetically transmitted section of population(11), and is
independently associated with hypertension (12) and also stimulates
the production of prothrombotic factors(13).
This study was designed to investigate the presence
of insulin resistance in the offsprings of young parents with CAD in
conjunction with lipid profile and other risk factors.
Subjects and Methods
The study material consisted of 50 children (age
5-18 years) of young parents with history of myocardial
ischemia/infarction (fathers <45 years of age and mothers <55 years of
age) proved by angiography, treadmill test, electrocardiogram and also
in presence of enzymes diagnostic of myocardial infarction. The
control group also consisted of 50 children of similar age group, of
parents less than 45 years of age and with history of atypical chest
pain, which proved to be normal on maximal treadmill test.
A detailed family history of cardio-vascular,
hepatic or renal disorders and diabetes mellitus was obtained in all.
This was followed by a detailed physical examination, anthropometry
and other investigations were carried out to exclude systemic
illnesses. Blood pressure (systolic and diastolic) was also measured
in all.
Processing of Blood Specimens
Blood samples were taken in a fasting state and
were processed for estimation of lipid profile and insulin levels. For
lipid profile, the blood sample was analysed in the Olympus
Auto-Analyzer and Insulin levels were measured by ELISA method using
DAKo Kit. The results were statistically analysed by the application
of student ‘t’ test and a 5% probability was considered significant.
Results
There were 50 children, each as test cases and
controls with a male to female ratio being 3:2. There was no
difference in the mean ages of the two groups e.g., 12 ± 4 years and
there was no difference in the anthropometric parameters or body mass
index (BMI).
Blood Pressure
There was a significant difference in the systolic
and diastolic blood pressures of the test cases (SBP-117 ± 14 mm Hg,
DBP-79 ± 9 mm Hg) and the controls (SBP-104 ± 8 mm Hg, DBP-69 ± 8 mm
Hg) and the difference was more marked in the 10-18 years.
Lipid Profile
Total serum cholesterol estimated were
significantly higher in test cases (169.68 ± 37.5 mg%) as compared to
controls (149.42 + 28.2 mg%). Similarly, LDL-cholesterol levels were
also significantly elevated in the test cases as compared to controls
(105.73 ± 36.43 vs 86.52 ± 25.91 mg%). But tri-glycerides and HDL-cholesterol
levels did not differ significantly in the two groups, neither was
there any significant difference in the other age groups.
Blood Sugar and Insulin Levels
There was an overall increase in the blood sugar
levels in the test cases as compared to controls (89.72 ± 13.49 mg% vs
84.36 ± 12.55 mg%) but the insulin levels were found to be
significantly elevated in test cases (34.79 ± 16.82 vs 26.47 ± 11.40
µ/U/ml) showing a definite insulin resistance in the older age groups.
Discussion
The prevalence, hospitalization and mortality from
CAD in Asian Indians is reported to be three to four times higher than
their European and American counterparts and even higher in comparison
to other Asians(14). The elevated risk of cardio-vascular disease in
patients with diabetes has been established for some time and the
insulin resistant phenotype is characterized by elevated levels of
plasma insulin, VLDL, triglycerides and free fatty acids.
Table I
Clinical Characteristics of the Study - Anthropometry & Blood Pressure.
|
Test cases |
Control |
|
|
5-9 years
(Mean ± SD) |
10- 18years
(Mean ± SD) |
5-18years
(Mean ± SD) |
P value
|
Age (Years)
|
7±2
|
12±4
|
12±4
|
0.721
|
Weight (Kg)
|
19±5
|
37±15
|
33±16
|
0.263
|
Z-Score(weight)
|
–1.69±0.66
|
–1.54±3.96
|
–1.55±1.55
|
0.988
|
Height (m)
|
1.17±0.13
|
1.43±0.23
|
1.38±0.24
|
0.304
|
Z-Score (height)
|
–1.37±2.25
|
–0.88±1.59
|
–1.57±1.59
|
0.029
|
BMI (kg/m)
|
13.92±2.87
|
17. 18±3.53
|
16.64±4.24
|
0.486
|
Blood Pressure
|
Systolic (mmHg)
|
109±13
|
117±14
|
104±8
|
0.000
|
Diastolic (mmHg)
|
74±8
|
79±9
|
69±8
|
0.000
|
TABLE II
Metabolic Variables of the Study.
|
Test cases |
Controls |
|
Lipid profile |
5-9years
(Mean ± SD) |
10-18 years
(Mean ± SD) |
5-18 years
(Mean ± SD) |
P value
|
Total Cholesterol(mg%)
|
173.40 ± 57.51
|
169.68 ± 37.45
|
149.42 ± 28.20
|
0.001
|
LDL-Cholesterol(mg%)
|
109.26 ± 60.69
|
105.73 ± 36.43
|
86.52 ± 25.91
|
0.003
|
HDL-Cholesterol(mg%)
|
41.80 ± 6.36
|
39.68 ± 6.43
|
37.46 ± 5.82
|
0.072
|
Triglycerides (mg%)
|
111.70 ± 33.75
|
121.28 ± 47.99
|
117.14 ± 38.96
|
0.637
|
Blood Sugar (mg%)
|
94.00 ± 13.31
|
89.72 ± 13.49
|
84.36 ± 12.55
|
0.042
|
Insulin (µ/U/ml)
|
21.02 ± 9.41
|
34.79 ± 16.82
|
26.47 ± 11.40
|
0.005
|
The results of the present study show significant
elevation of blood pressure, total serum cholesterol, LDL-C and
elevated insulin levels in the test cases. Adolescents (10-18 yrs) are
specially at "high risk" being vulnerable for adult diseases within a
short period of time. There was no significant difference in the
weight and body mass index (BMI) of the test cases and controls in the
individual age groups.
The findings of Bogalusa Heart Study were similar
to the present study, where the mean levels in offsprings of parents
with CAD were found to be significantly higher com-pared to normal
children(15). In addition a significant difference was detected in the
total cholesterol as well as LDL-Cholesterol but there was no
difference in triglycerides or HDL-Cholesterol levels.
All these findings are significant in the light of
longitudinal observations in children of young adults showing that
levels of serum lipids and lipoproteins persist for sometime -tracking
of total and LDL-cholesterol and apolipoprotein B(16).
The mechanisms underlying insulin resistance remain
incompletely understood but it is clearly promoted by obesity and
physical inactivity acting on a background of genetic
susceptibility(17). In the present study, no difference was found in
the weight and body mass index (BMI) of the test cases and controls
and the biochemical parameters were elevated in the adolescent age
groups (10-18 years), thereby signifying that it indicates a metabolic
alteration superadded on a genetic back-ground. Though both weight and
BMI influence insulin resistance and lipid profile, it might be
interpreted that family history of premature CAD is probably
responsible for a predisposition to the above mentioned meta-bolic
syndrome. The National Cholesterol Education Panel III (NCEP ATPIII)
recently has suggested a simple definition of meta- bolic syndrome,
which includes upper body obesity, high triglyceride levels, low HDL-cholesterol,
hypertension and impaired fasting glucose. Individuals who have 3 or
more of the components are defined as having the above mentioned
metabolic syndrome(18). In the present study, dyslipidemia with
elevated insulin levels were present in 42% of test cases in contrast
to22% of controls - who can be labelled as those "at risk" where,
interventions are indicated.
The prevention Of CAD can be achieved by breaking
the link in the chain of events leading on to Atherosclerosis.
Interventions should be directed against the identified risk factors,
which include obesity, hypertension and dyslipidemia. To counteract
obesity and hypertension, balanced diet is needed along-with physical
activity in the form of yoga, aerobic exercises and walking.
In conclusion, "insulin resistance syn-drome" may
be detected early in life, putting them in the "high risk" group. A
higher section of pediatric population should be screened for BMI,
lipid profile and insulin levels and those "at risk" followed up.
Contributors: AK designed the project, drafted the
manuscript and will act as the guarantor; VP selected the patients,
collected the samples and got the tests done; JB was responsible for
the biochemical work-up of the project.
Funding: None.
Competing interests: None stated.
Key Message |
• Serum cholesterol, blood sugar, blood pressure and insulin
level were significantly high in offsprings of young CAD
patients.
• Insulin Resistance syndrome may be picked up in the
adolescent age group and interventions started in those "at
risk" .
|
References
|
1. Enas EA, Yusuf S, Sharma S: Coronary
artery disease in south Asians-second meeting of the
International working group, 16 March 1997, Anaheim, Calaiformia.
— IHJ 1998; 50: 105-113.
2. Reddy KS, Yusuf S. Emerging epidemic of
cardiovascular disease in developing countries. Circulation
1998; 97: 596-601.
3. Gupta R. Coronary heart disease
epidemiology in India: the past, present and future. In: Rao GHR
(ed) Coronary artery disease in South Asians. New Delhi,
Jaypee 2001, pp 6-28.
4. Wu Z, Yao C, Thao D, Wu G, Wang W, Lin J
et al. Sino-MONICA. Project: a collaborative study on
trends and determinants in cardiovascular diseases in China,
Part I: Morbidity and mortality monitoring -Circulation 2001;
103: 462-468.
5. Enas EA, Senthil Kumar A, Juturu V, Gupta
R. Coronary artery disease in women: IHJ 2001; 53: 282-292.
6. Berenson GS, Srinivasan SR. Emergence of
obesity and cardiovascular risk for coronary artery disease: The
Bogalusa Heart Study - Prev Cardiol 2001; 4: 116-121.
7. Wheatcroft SB, Williams IL, Kearney MT.
Insulin resistance, the endothelium and atherosclerosis. Br J
Cardiol 2001; 8(10): 580-585.
8. Reaven GM: Bauting lecture 1988: Role of
insulin resistance in human disease- Diabetes 1988; 37:
1595-1607.
9. Ruige JB, Assendelft WJI, Dekker JM, et
al. Insulin and risk of cardiovascular disease: A
metaanalysis. Circulation 1998; 97: 996-1001.
10. Despres JP, Lamarch B, Mauriege P et al.
Hyper insulinemia as an independent risk factor for ischemic
heart disease. N Engl. J Med. 1996; 334: 952-957.
11. Hong Y, Pederson NL, Brissmar K, DeFaire
V: Genetic and environmental architecture of the features in
insulin resistance syndrome. Am J Hum Genet. 1997; 60: 143.
12. Ferramni E, Buzzigoli G, Bonnadonna R,
BrandiL, Beoilaacqua S et al. Insulin resistance in
essential hypertension. N Engl. J Med 1987; 317: 350-357.
13. Haffner M, Stern MP, Mitchell BD, Hazuda
HP, Patterson JR. Incidence of type II diabetes in Mexican
American predicted by fasting insulin level glucose levels,
obesity and body fat distributions. Diabetes 1990; 39: 283-288.
14. Jha P, Evas EA, Yusuf S. Coronary artery
disease in Asian Indians: prevalence and risk factors. Asian Am
Pac. Islander J Health 1993; 1: 161-175.
15. Greenlund KJ, Valdez R, Bao W, Wattigney
WA, Srinivasan SR, Berenson GS. Verification of parental history
of coronary artery disease and associations with adult offspring
risk factors in a community sample: The Bogalusa Heart Study. Am
J Med Sc. 1997; 313: 220-227.
16. Bao W, Srinivasan SR, Berenson GS.
Tracking of serum apolipoprotein A-I and B in children and young
adults: The Bogalusa Heart Study. J Clin Epidemiol 1993; 46:
609-616.
17. Chisholm DJ, Campbell LV, Kraegen EW.
Pathogenesis of the insulin resistance syndrome (Syndrome X).
Clin Exp Pharmacol Physiol 1997; 24: 782-784.
18. Expert Panel on detection, evaluation and treatment of
high blood cholesterol in adults (Adult treatment Panel III)&
Executive summary of the third report of the National Conference
Education Programme (NCEP). JAMA 2001; 285: 2486-2497.
| |